MariMed Statistics
Total Valuation
MariMed has a market cap or net worth of 27.38 million. The enterprise value is 120.64 million.
| Market Cap | 27.38M |
| Enterprise Value | 120.64M |
Important Dates
The next estimated earnings date is Wednesday, August 6, 2025.
| Earnings Date | Aug 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MariMed has 391.19 million shares outstanding. The number of shares has increased by 2.55% in one year.
| Current Share Class | 391.19M |
| Shares Outstanding | 391.19M |
| Shares Change (YoY) | +2.55% |
| Shares Change (QoQ) | +0.34% |
| Owned by Insiders (%) | 10.41% |
| Owned by Institutions (%) | 0.29% |
| Float | 350.46M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.17 |
| PB Ratio | 0.37 |
| P/TBV Ratio | 1.38 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 5.63 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.37, with an EV/FCF ratio of -30.24.
| EV / Earnings | -7.39 |
| EV / Sales | 0.76 |
| EV / EBITDA | 8.37 |
| EV / EBIT | 118.39 |
| EV / FCF | -30.24 |
Financial Position
The company has a current ratio of 1.05, with a Debt / Equity ratio of 1.18.
| Current Ratio | 1.05 |
| Quick Ratio | 0.30 |
| Debt / Equity | 1.18 |
| Debt / EBITDA | 6.07 |
| Debt / FCF | -21.93 |
| Interest Coverage | 0.14 |
Financial Efficiency
Return on equity (ROE) is -20.10% and return on invested capital (ROIC) is 0.38%.
| Return on Equity (ROE) | -20.10% |
| Return on Assets (ROA) | 0.31% |
| Return on Invested Capital (ROIC) | 0.38% |
| Return on Capital Employed (ROCE) | 0.67% |
| Revenue Per Employee | 204,116 |
| Profits Per Employee | -21,083 |
| Employee Count | 832 |
| Asset Turnover | 0.77 |
| Inventory Turnover | 2.90 |
Taxes
In the past 12 months, MariMed has paid 9.30 million in taxes.
| Income Tax | 9.30M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -64.10% in the last 52 weeks. The beta is 3.00, so MariMed's price volatility has been higher than the market average.
| Beta (5Y) | 3.00 |
| 52-Week Price Change | -64.10% |
| 50-Day Moving Average | 0.08 |
| 200-Day Moving Average | 0.12 |
| Relative Strength Index (RSI) | 39.80 |
| Average Volume (20 Days) | 341,793 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.11 |
Income Statement
In the last 12 months, MariMed had revenue of 157.99 million and -16.32 million in losses. Loss per share was -0.04.
| Revenue | 157.99M |
| Gross Profit | 61.53M |
| Operating Income | 1.02M |
| Pretax Income | -6.96M |
| Net Income | -16.32M |
| EBITDA | 12.32M |
| EBIT | 1.02M |
| Loss Per Share | -0.04 |
Balance Sheet
The company has 7.20 million in cash and 87.51 million in debt, giving a net cash position of -80.31 million or -0.21 per share.
| Cash & Cash Equivalents | 7.20M |
| Total Debt | 87.51M |
| Net Cash | -80.31M |
| Net Cash Per Share | -0.21 |
| Equity (Book Value) | 73.94M |
| Book Value Per Share | 0.16 |
| Working Capital | 2.69M |
Cash Flow
In the last 12 months, operating cash flow was 4.87 million and capital expenditures -8.86 million, giving a free cash flow of -3.99 million.
| Operating Cash Flow | 4.87M |
| Capital Expenditures | -8.86M |
| Free Cash Flow | -3.99M |
| FCF Per Share | -0.01 |
Margins
Gross margin is 38.95%, with operating and profit margins of 0.64% and -10.33%.
| Gross Margin | 38.95% |
| Operating Margin | 0.64% |
| Pretax Margin | -4.40% |
| Profit Margin | -10.33% |
| EBITDA Margin | 7.80% |
| EBIT Margin | 0.64% |
| FCF Margin | n/a |
Dividends & Yields
MariMed does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.55% |
| Shareholder Yield | -2.55% |
| Earnings Yield | -59.59% |
| FCF Yield | -14.57% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MariMed has an Altman Z-Score of 0.29 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.29 |
| Piotroski F-Score | 3 |